INDP insider transaction filings
Indaptus Therapeutics, Inc. — 41 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-24. Screen INDP transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for INDP between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Indaptus Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-24 | 4 | Lazar David E. — Director | Sale (S): 196,800 (derivative) · Sale (S): 700,000 (derivative) | EDGAR |
| 2026-02-27 | 4 | Jabbour Jerome D — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Meckler Jeffrey A — Co-Chief Executive Officer, Director | Disposition to issuer (D): 3,033 (derivative) · Grant/award (A): 3,033 (derivative) · Disposition to issuer (D): 1,519 (derivative) · Grant/award (A): 1,519 (derivative) · Disposition to issuer (D): 12,136 (derivative) · Grant/award (A): 12,136 (derivative) | EDGAR |
| 2026-01-22 | 4 | Ben-Tzvi Avraham — Director | Grant/award (A): 25,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | NATAN DAVID — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Newman Michael James — CSO and Director, Director | Grant/award (A): 52,204 @ $2.03 | EDGAR |
| 2025-12-29 | 4 | Sassi Nir — Chief Financial Officer | Grant/award (A): 26,758 @ $2.03 | EDGAR |
| 2025-12-29 | 4 | Linscott Walt Addison — Chief Operating Officer | Grant/award (A): 54,421 @ $2.03 | EDGAR |
| 2025-12-29 | 4 | Meckler Jeffrey A — Co-Chief Executive Officer, Director, 10% owner | Grant/award (A): 216,617 @ $2.03 | EDGAR |
| 2025-07-29 | 4 | Meckler Jeffrey A — Chief Executive Officer, Director | Grant/award (A): 6,068 @ $8.30 · Grant/award (A): 12,136 (derivative) @ $8.30 | EDGAR |
| 2025-06-11 | 4 | Gilbert Mark John — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Karah Hila — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Pomerantz Roger — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | MADDALUNA ANTHONY J — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Martell Robert — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Hayes William B — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Sassi Nir — Chief Financial Officer | Disposition to issuer (D): 1,250 (derivative) @ $0.07 · Disposition to issuer (D): 1,125 (derivative) @ $0.07 · Disposition to issuer (D): 2,500 (derivative) @ $0.07 · Disposition to issuer (D): 500 (derivative) @ $0.07 · Disposition to issuer (D): 500 (derivative) @ $0.07 · Disposition to issuer (D): 41 (derivative) @ $0.07 · +1 more | EDGAR |
| 2025-04-11 | 4 | Karah Hila — Director | Disposition to issuer (D): 500 (derivative) @ $0.39 · Disposition to issuer (D): 250 (derivative) @ $0.39 · Disposition to issuer (D): 281 (derivative) @ $0.39 · Disposition to issuer (D): 250 (derivative) @ $0.39 | EDGAR |
| 2025-04-11 | 4 | Linscott Walt Addison — Chief Operating Officer | Disposition to issuer (D): 1,750 (derivative) @ $0.06 · Disposition to issuer (D): 750 (derivative) @ $0.06 · Disposition to issuer (D): 1,250 (derivative) @ $0.06 · Disposition to issuer (D): 1,125 (derivative) @ $0.06 · Disposition to issuer (D): 2,500 (derivative) @ $0.06 · Disposition to issuer (D): 1,125 (derivative) @ $0.06 | EDGAR |
| 2025-04-11 | 4 | Pomerantz Roger — Director | Disposition to issuer (D): 500 (derivative) @ $0.50 · Disposition to issuer (D): 250 (derivative) @ $0.50 · Disposition to issuer (D): 250 (derivative) @ $0.50 | EDGAR |
| 2025-04-11 | 4 | MADDALUNA ANTHONY J — Director | Disposition to issuer (D): 500 (derivative) @ $0.50 · Disposition to issuer (D): 250 (derivative) @ $0.50 · Disposition to issuer (D): 250 (derivative) @ $0.50 | EDGAR |
| 2025-04-11 | 4 | Meckler Jeffrey A — Chief Executive Officer, Director | Disposition to issuer (D): 4,750 (derivative) @ $0.04 · Disposition to issuer (D): 3,750 (derivative) @ $0.04 · Disposition to issuer (D): 813 (derivative) @ $0.04 · Disposition to issuer (D): 1,500 (derivative) @ $0.04 · Disposition to issuer (D): 1,563 (derivative) @ $0.04 · Disposition to issuer (D): 1,250 (derivative) @ $0.04 | EDGAR |
| 2025-04-11 | 4 | Hayes William B — Director | Disposition to issuer (D): 500 (derivative) @ $0.50 · Disposition to issuer (D): 250 (derivative) @ $0.50 · Disposition to issuer (D): 250 (derivative) @ $0.50 | EDGAR |
| 2024-11-26 | 4 | Meckler Jeffrey A — CEO and Director, Director | Grant/award (A): 42,553 @ $1.18 · Grant/award (A): 42,553 (derivative) @ $1.18 | EDGAR |
| 2024-10-10 | 4 | Newman Michael James — CSO and Director, Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | Sassi Nir — Chief Financial Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | Waltzman Roger J. — Chief Medical Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | Linscott Walt Addison — Chief Operating Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | Meckler Jeffrey A — CEO and Director, Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | Meckler Jeffrey A — CEO and Director, Director | Grant/award (A): 84,932 @ $1.82 · Grant/award (A): 84,932 (derivative) @ $1.82 | EDGAR |
| 2024-06-07 | 4 | Gilbert Mark John — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Karah Hila — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Pomerantz Roger — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | MADDALUNA ANTHONY J — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Martell Robert — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Hayes William B — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Newman Michael James — CSO and Director, Director, 10% owner | Grant/award (A): 43,250 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Sassi Nir — Chief Financial Officer | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Waltzman Roger J. — Chief Medical Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Linscott Walt Addison — Chief Operating Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Meckler Jeffrey A — CEO and Director, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Indaptus Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-08 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=INDP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →